Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
Nobuyuki
N
Tetsuka
Medical Mycology Research Center, Chiba University, Chiba, Japan.
Takashi
T
Yaguchi
Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Hiroyuki
H
Machida
Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Shuichi
S
Ito
Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
Isao
I
Miyairi
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001230:Aspergillus / Q000187:drug effects* / Q000302:isolation & purification; D002648:Child; D025141:Drug Resistance, Fungal; D054714:Echinocandins / Q000627:therapeutic use*; D006801:Humans; D055744:Invasive Pulmonary Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D055666:Lipopeptides / Q000627:therapeutic use*; D008297:Male; D000077551:Micafungin; D065819:Voriconazole / Q000494:pharmacology / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D065819:Voriconazole; D000077551:Micafungin

Aspergillus lentulus
; child; immunocompromised; invasive pulmonary aspergillosis; micafungin